Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS)

Multiple Sclerosis Journal

Volumn 19, Issue 4, 2013, Pages 502-505

  Mills, R J ^a   Calabresi, M ^a   Tennant, A ^b   Young, C A ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Fatigue; Outcome measurement; Rasch analysis

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGICAL FATIGUE INDEX FOR MULTIPLE SCLEROSIS; NIGHT SLEEP; RASCH ANALYSIS; RATING SCALE;

EID: 84877853035     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512457840     Document Type: Article

References (6)

1. Mills RJ, Young CA, Pallant J, et al. Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI). Health Qual Life Outcomes 2010; 8: 22.
2. Chuang-Stein C, Kirby S, Hirsch I, et al. The role of the minimum clinically important difference and its impact on designing a trial. Pharm Stat 10: 250-256.
3. King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 11: 171-184.
4. Revicki DA, Cella D, Hays RD, et al. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes 2006; 4: 70.
5. Shikiar R, Willian MK, Okun MM, et al. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 2006; 4: 71.
6. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452. (Pubitemid 14237132)